Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Neograstim 30MU Syringe


Contraindicated
Reproductive toxicity in animals

Contraindicated
Neograstim 30MU Syringe :
Type Medicine Authorised
Originator Nivestim 30MU Syringes
Agent Benta Trading Co
Distributor Benta Trading Co
Laboratory Benta Laboratories
Responsible Party Benta SAL
Origin Lebanon
Manufacturer Benta SAL
Manufacturing Type G
Origin Lebanon
ATC L03AA02

Your comment will appear shortly after approval

Neograstim 30MU Syringe :

Revision Date : 06/02/2015


Effect Frequency
Acute febrile neutrophilic dermatosis (Sweet's syndrome) Uncommon
Acute respiratory distress syndrome Uncommon
Alopecia Very Common
Anaemia Very Common
Anaphylaxis Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anorexia Very Common
Arthralgia (Pain joint) (Joint ache) Very Common
AST increased Uncommon
Asthenia Very Common
Back pain Very Common
Blood alkaline phosphatase increased Very Common
Blood glucose decreased Very Common
Blood lactate dehydrogenase increased Very Common
Blood uric acid increased Very Common
Bone density decreased Common
Bone pain Very Common
Capillary leak syndrome Uncommon
Chest pain Common
Constipation Very Common
Cough Very Common
Cutaneous vasculitis Common
Diarrhoea (Diarrhea) Very Common
Drug hypersensitivity Common
Dyspnoea (dyspnea) Very Common
Dysuria (Micturition painful) Common
Epistaxis (Nasal bleeding) Very Common
Fatigue Very Common
Fluid volume Disturbances Uncommon
Gamma-GT increased Very Common
Graft versus host disease Uncommon
Haematuria (Hematuria) Common
Haemoptysis Common
Headache Very Common
Hepatomegaly Very Common
Hypersensitivity Not known
Hyperuricaemia Very Common
Hypotension Common
Hypoxia Uncommon
Injection site reaction Common
Interstitial pneumonitis Uncommon
Leukaemia Not known
Leukocytosis Very Common
Lung infiltration (pulmonary infiltration) Uncommon
Mucosal inflammation Very Common
Musculoskeletal chest pain Very Common
Musculoskeletal pain Very Common
Myalgia Very Common
Myelodysplastic syndrome Not known
Nausea Very Common
Neck pain Very Common
Osteoporosis Common
Pain Uncommon
Pain in extremity (Pain in limb) Very Common
Pharyngolaryngeal pain Very Common
Proteinuria Uncommon
Pseudogout Uncommon
Pulmonary haemorrhage Uncommon
Pulmonary oedema Uncommon
Respiratory failure Uncommon
Rheumatoid arthritis aggravated Uncommon
Sickle cell crisis Uncommon
Skin rash Very Common
Splenic rupture Common
Splenomegaly (Spleen enlarged) Very Common
Thrombocytopenia (Thrombopenia) Very Common
Urine abnormality Uncommon
Urticaria Not known
Venoocclusive disease Uncommon
Vomiting Very Common

Different Units By MoH Code

Revision Date : 01/11/2012

Neograstim 30MU Syringe Neograstim 30MU Syringe Neograstim 30MU Syringe Neograstim 30MU Syringe Neograstim 30MU Syringe Neograstim 30MU Syringe Neograstim 30MU Syringe

Neograstim 30MU Syringe  MoH 5343 :
Form Solution for injection
Packaging Pre-filled Syringe
Package Size 1x1ml
Strength 30MU
Public Price 1970969 L.L.
Stratum B
NSSF ✔
Quarantine ✘
Reg. Number 222447/08
Submission date 01/01/2008
Registration Year 2009


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x1ml
● Public Price: 1970969 LBP ( 1,970,969.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1970969 LBP ( 1,970,969.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info